A reconstitution step can look straightforward at the bench, yet become difficult to reproduce weeks later if the record is thin. Before a new in-vitro assay is booked, the documentation should let a colleague pick up the same vial, diluent and calculation trail and explain exactly what was done, why it was done that way, and which batch documents were checked. For Research Sciences research-use-only materials, that record should sit alongside the batch CoA rather than replace it. These materials are for controlled laboratory and analytical research only; they are not for human or veterinary use.
Good documentation is not administrative decoration. It turns a physical action into a repeatable method, separates observation from inference, and highlights anything a colleague must verify before committing an assay slot. The aim is not a perfect narrative written afterwards; it is a practical bench record made at the time and reviewed before the next person relies on it.
Plan the Record Before the Assay Slot Is Confirmed
Before booking the assay, agree what “repeat” means for the experiment: the same final concentration in the in-vitro system, the same diluent, the same vial reference, or the same handling window. Write that requirement into the protocol version so the reconstitution record has a clear purpose. A record that answers the wrong question can be detailed and still unusable.
Fix the document set first. The batch CoA is the controlling document for the identity and purity statements supplied with the material, so open it and check it before the record is signed off. Research Sciences describes CoAs for products and batch-level analytical documentation; the exact wording and values should be reconfirmed on the live batch CoA rather than copied from a homepage or an old screenshot. If the protocol allows an alternative catalogue item, review the current listing before committing the slot; the all-products category is the place to Buy peptides and then check the individual product page and its batch CoA.
Record the vial label reference in the format used by the supplier, which combines the SKU code and expiry date, such as BPC10-03/27. Quote that reference when contacting the shop about documentation. Do not infer identity or quality from vial cap colour; packaging may vary and cap colour is not an indicator of analytical quality or manufacturing origin. If a restocked product carries the same Internal Test Reference as earlier stock, treat the ITR as a link to associated sample testing reports, not as confirmation that separate deliveries came from the same production lot or had separate independent testing.
Start with the question the record must answer
A useful opening line is: “This record should allow a competent colleague to repeat the reconstitution at the stated final concentration for the named in-vitro assay using the same batch and diluent.” That sentence keeps the record focused on laboratory use and prevents it drifting into undocumented assumptions. Add the assay identifier, protocol version and the name of the person booking the slot. The materials remain research-use-only and must not be described or handled as medicines, supplements or veterinary products.
Write the Bench Record in a Way Another Researcher Can Follow
At the bench, record identity before volume. Capture the product name, catalogue item, label reference, batch CoA identifier, and any ITR shown on the documentation. Note the vial condition on receipt or removal from storage, including whether it was sealed and protected from light. Research Sciences describes temperature-aware storage and tracked UK dispatch, but delivery estimates and current published wording should be reconfirmed at checkout; the record should rely on the actual batch documents supplied.
Record the diluent and the calculation trail
Record the diluent by exact label wording and lot. The catalogue includes both “10ml Mixing Water” and “Bacteriostatic Water 10ml” wording, so copying the label prevents ambiguity later. Write the diluent volume added, the intended final concentration for the in-vitro assay, the formula used, and the name of the person who checked the calculation. If the free peptide reconstitution calculator is used, record the inputs and outputs and verify them independently; the calculator is for laboratory research use only and must not be used for human or veterinary dosing.
Capture handling, observations and storage
Note that the vial and diluent were allowed to reach ambient temperature before opening in the research setting, that work took place in a clean environment, and that only the amount required for the experiment was removed. Record visible observations such as appearance, any visible particles, or deviations from the expected procedure, without inventing pass/fail limits. Label the reconstituted material with concentration, diluent, preparation date and time, operator initials and storage conditions. The site’s guidance describes reconstituted peptides as less stable and recommends short-term laboratory storage at 2–8°C, with lyophilised stock kept at −20°C or below, sealed with desiccant and protected from moisture, heat and light; avoid repeated freeze–thaw cycles.
Include any excipient information noted in the product documentation, such as trace mannitol, so a colleague does not mistake it for an added assay component. The label should still carry the research-use-only status: “For Research Use Only – Not for Human Consumption”. These materials are not for human or veterinary use, and the purchaser remains responsible for lawful use, safe handling, storage and disposal under relevant UK laboratory requirements.
Have a Colleague Dry-Run the Record Before the Assay Starts
A second researcher should read the record without prompting and explain the steps back: which vial, which CoA, which diluent lot, which volume, which final concentration, which storage condition. If the colleague has to ask where a value came from, the record needs a clearer entry. The dry run is not a comment on biological outcome; it is a check that the reconstitution step is repeatable.
Review against the CoA and the protocol
Compare the record with the batch CoA, the current product page and the approved protocol. Check that the label reference matches the document set, that the diluent wording matches the label, and that the calculation is independently reproducible. Confirm that any statement about purity, identity or testing is attributed to the batch CoA and the shop’s current published wording, not to memory. If the record cites a published figure, add a note to reconfirm it on the live site and on the batch CoA where relevant.
Release the assay slot only after the dry run
Use a simple review block: reviewer name, review date, queries raised, resolution, and approval to book. Do not release the assay slot if the batch CoA is missing, the vial reference is unclear, the diluent lot is absent, or the calculation trail cannot be followed. If a fresh order is needed, wait until the batch CoA and label reference can be written into the record. The final sign-off should state that the documentation is sufficient for a colleague to repeat the reconstitution and that all materials remain strictly research-use-only, not for human or veterinary use.